期刊文献+

移植肾急性肾衰竭的救治 被引量:1

原文传递
导出
摘要 由于肾脏移植手术技巧的改进及新型免疫抑制剂和免疫抑制方案的进展,移植肾的近期生存率与长期生存率均有很大的提高,但肾移植至今仍面临许多亟待解决的困难。肾移植受者因其特殊性,发生急性肾衰竭(ARF)的可能性远高于一般人群。移植后早期的基础肾功能对移植肾长期生存有重要影响,故移植肾ARF的救治成功与否成为影响移植肾长期生存的突出问题。
出处 《中华内科杂志》 CAS CSCD 北大核心 2007年第1期13-15,共3页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献4

二级参考文献44

  • 1Becker BN, Becker YT, Leverson GE, et al. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation. Am J Kidney Dis, 2002,39: 1088-1095.
  • 2Landolfo S, Gariglio M, Gribaudo G, et al. The human cytomegalovirus. Pharmacol Ther, 2003,98: 269-297.
  • 3Cainelli F, Vento S. Infections and solid organ transplant rejection: a cause-and-effect relationship? Lancet Infect Dis,2002,2: 539-549.
  • 4Kim CK, Song JH, Kim SM, et al. Clinical usefulness of human cytomegalovirus antigenemia assay after kidney transplantation. Transplantation, 2003,75: 2151-2155.
  • 5Lee W,Tsang WK,Tong KL,et al. Cytomegalovirus infection and graft rejection in renal transplantation: a single-center experience. Transplant Proc,2003, 35: 282-283.
  • 6Dickenmann M J, Cathomas G, Steiger J, et al. Cytomegalovirusinfection and graft rejection in renal transplantation.Transplantation, 2001,71: 764-767.
  • 7Sageda S, Nordal KP, Hartmann A, et al. The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant, 2002,2: 850-856.
  • 8McLaughlin K, Wu C, Fick G, et al. Cytomegalovirus seromismatching increases the risk of acute renal allograft rejection. Transplantation, 2002,74: 813-816.
  • 9Fitzgerald JT,Gallay B,Taranto SE,et al. Pretransplant recipient cytomegalovirus seropositivity and hemodialysis are associated with decreased renal allograft and patient survival.Transplantation, 2004,77: 1405-1411.
  • 10Sagedal S,Nordal KP,Hartmann A,et al. Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir:a randomized, comparative study. Nephrol Dial Transplant, 2003,18: 1899-1908.

共引文献30

同被引文献15

  • 1华梓婷,郭养浩,孟春,刘晓楠.细胞色素P450的基因多态性与药物代谢[J].中国新药杂志,2007,16(7):510-515. 被引量:21
  • 2Segall L,Covic A.Diagnosis of tuberculosis in dialysis patients:current strategy.Clin J Am Soc Nephrol,2010,5:1114-1122.
  • 3Richardson RM.The diagnosis of tuberculosis in dialysis patients.Semin Dial,2012,25:419-422.
  • 4Agarwal R,Nissenson AR,Batlle D,et al.Prevalence,treatment,and control of hypertension in chronic hemodialysis patients in the United States.Am J Med,2003,115:291-297.
  • 5K/DOQI Workgroup.K/DOQI clinical practice guidelines forcardiovascular disease in dialysis patients.Am J Kidney Dis,2005,45:S1-153.
  • 6Davenport A,Cox C,Thuraisingham R.Achieving blood pressuretargets during dialysis improves control but increases intradialytic hypotension.Kidney Int,2008,73:759-764.
  • 7H(o)rl MP,H(o)rl WH.Hemodialysis-associated hypertension:pathophysiology and therapy.Am J Kidney Dis,2002,39:227-244.
  • 8Laurent G.How to keep the dialysis patients normotensive? What is the secret of Tassin?.Nephrol Dial Transplant,1997,12.
  • 9Niemi M,Backman JT,Fromm MF,et al.Pharmacokinetic interactions with rifampicin:clinical relevance.Clin Pharmacokinet,2003,42:819-850.
  • 10Wilkinson GR.Drug metabolism and variability among patients in drug response.N Engl J Med,2005,352:2211-2221.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部